We believe our products have the potential to impact people's lives. That's why we're thrilled to present our unique offerings.
See approved products below.
endocrinology
| Product logo | Product name | Description |
|---|---|---|
|
Gvoke HypoPen®
(glucagon injection)
|
Gvoke HypoPen® is the first FDA-approved autoinjector for very low blood sugar that is premixed and ready to use. It is a prescription medicine used to treat very low blood sugar (severe hypoglycemia) in adults and children ages 2 years and above with diabetes. It is available in both pediatric (0.5mg/0.1mL) and adult (1.0mg/0.2mL) doses. |
|
Recorlev®
(levoketoconazole)
|
RECORLEV® is a cortisol synthesis inhibitor indicated for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an option or has not been curative. Limitations of Use |
gastroenterology
| Product logo | Product name | Description |
|---|---|---|
|
Gvoke VialDxTM
|
Gvoke VialDxTM (glucagon injection) is a gastrointestinal motility inhibitor indicated for intravenous use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients. |
neurology
| Product logo | Product name | Description |
|---|---|---|
|
Keveyis®
(dichlorphenamide)
|
KEVEYIS® is the first FDA-approved treatment for Primary Periodic Paralysis. It is a prescription drug used to treat primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants. |